Laboratory Corp. (LH) Misses Q2 EPS by 1c; Adjusts FY12 Outlook
Tweet
Share
E-mailGet Alerts LH Hot Sheet
Price: $326.89 -1.39%
EPS Growth %: +11.2%
Financial Fact:
Interest expense: -58.2M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +11.2%
Financial Fact:
Interest expense: -58.2M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Laboratory Corp. (NYSE: LH) reported Q2 EPS of $1.77, $0.01 worse than the analyst estimate of $1.78. Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.44 billion.
Laboratory Corp. sees FY2012 EPS of $6.80-$7.00, versus the consensus of $6.97. Laboratory Corp. sees FY2012 revenue increasing 2.0% - 3.0%.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.
Laboratory Corp. sees FY2012 EPS of $6.80-$7.00, versus the consensus of $6.97. Laboratory Corp. sees FY2012 revenue increasing 2.0% - 3.0%.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
